1. Novel hybrid conjugates with dual estrogen receptor α degradation and histone deacetylase inhibitory activities for breast cancer therapy
   Chenxi Zhao et al, 2021, Bioorganic & Medicinal Chemistry CrossRef
2. Estrogen Receptor Is Required for Metformin-Induced Apoptosis in Breast Cancer Cells Under Hyperglycemic Conditions
   Andisyah Putri Sekar et al, 2024, Breast Cancer: Basic and Clinical Research CrossRef
3. Current trends in the treatment of HR+/HER2+ breast cancer
   Charlene Kay et al, 2021, Future Oncology CrossRef
4. Recent advances and limitations in the application of kahalalides for the control of cancer
   Scott Wyer et al, 2022, Biomedicine & Pharmacotherapy CrossRef
5. Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer
   Adam L. Maddox et al, 2022, Cancers CrossRef
6. ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
   Ruibin Yi et al, 2020, Frontiers in Genetics CrossRef
7. Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer
   Sean P. Kennedy et al, 2020, Oncogene CrossRef
8. PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China
   Xiaoyu Liu et al, 2023, World Journal of Surgical Oncology CrossRef
9. Multiple receptor tyrosine kinases regulate dengue infection of hepatocytes
   Natasha M. Bourgeois et al, 2024, Frontiers in Cellular and Infection Microbiology CrossRef
10. Preclinical models for precision oncology
    Maider Ibarrola-Villava et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
11. Evaluation of protein functionalized gold nanoparticles to improve tamoxifen delivery: synthesis, characterization, and biocompatibility on breast cancer cells
    Oznur Akbal Vural, 2022, International Journal of Polymeric Materials and Polymeric Biomaterials CrossRef
12. Clinical and Genetic Predictive Models for the Prediction of Pathological Complete Response to Optimize the Effectiveness for Trastuzumab Based Chemotherapy
    Lun Li et al, 2021, Frontiers in Oncology CrossRef
13. Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies
    Sabrina Rizzolio et al, 2018, Journal of Clinical Investigation CrossRef
14. OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth
    Rheal A. Towner et al, 2019, Translational Oncology CrossRef
15. Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2+ breast cancer
    Donna O. Debets et al, 2023, Cell Reports Medicine CrossRef
16. Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial
    Serena Di Cosimo et al, 2020, Breast Cancer Research CrossRef
17. Drugging IGF-1R in cancer: New insights and emerging opportunities
    Panpan Wang et al, 2023, Genes & Diseases CrossRef
18. IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches
    J. Selfe et al, 2019, Andrology CrossRef
19. Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer
    Mark Pegram et al, 2023, npj Breast Cancer CrossRef